Patent Claims for Prenatal Diagnostic Method Invalidated as Ineligible Subject Matter

The U.S. District Court for the Northern District of California found Sequenom's patent claims on a prenatal diagnostic method to be invalid and not infringed by Arisoa Diagnostic's Harmony Test product, because the asserted claims were directed at...
By: Jeffer Mangels Butler & Mitchell LLP

Jeffer Mangels Butler & Mitchell LLP